Suppr超能文献

提高新冠疫苗接种率并减少接受肾脏替代治疗患者的健康不平等现象——来自一家三级中心的经验

Increasing Uptake of COVID-19 Vaccination and Reducing Health Inequalities in Patients on Renal Replacement Therapy-Experience from a Single Tertiary Centre.

作者信息

Poulikakos Dimitrios, Chinnadurai Rajkumar, Anwar Saira, Ahmed Amnah, Chukwu Chukwuma, Moore Jayne, Hayes Emma, Gorton Julie, Lewis David, Donne Rosie, Lamerton Elizabeth, Middleton Rachel, O'Riordan Edmond

机构信息

Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UK.

Faculty of Biology, Medicine, and Health, University of Manchester, Manchester M13 9PL, UK.

出版信息

Vaccines (Basel). 2022 Jun 13;10(6):939. doi: 10.3390/vaccines10060939.

Abstract

BACKGROUND

COVID-19 vaccination has changed the landscape of the COVID-19 pandemic; however, decreased uptake due to vaccine hesitancy has been observed, particularly in patients from minority ethnic backgrounds and socially deprived areas. These patient characteristics are common in patients on Renal Replacement Therapy (RRT), a population at extremely high risk of developing serious illness from COVID-19 and who would thus benefit the most from the vaccination programme. We designed a bespoke COVID-19 vaccination programme for our RRT population with the aim of decreasing health inequalities and increasing vaccination uptake.

METHODS

Key interventions included addressing vaccine hesitancy by deploying the respective clinical teams as trusted messengers, prompt eligible patient identification and notification, the deployment of resources to optimise vaccine administration in a manner convenient to patients, and the timely collection and analysis of local safety and efficacy data. First, COVID-19 vaccination data in relation to ethnicity and social deprivation in our RRT population, measured by the multiple deprivation index, were analysed and compared to uptake data in the total regional adult clinically extremely vulnerable (CEV) population in Greater Manchester (GM). Univariate logistic regression analysis was used to explore the factors associated with not receiving a vaccine.

RESULTS

Out of 1156 RRT patients included in this analysis, 96.7% received the first dose of the vaccination compared to 93% in the cohort of CEV patients in the GM. Age, gender, ethnicity, and a lower index of multiple deprivation were not identified as significant risk factors for poor first dose vaccine uptake in our cohort. Vaccine uptake in Asian and Black RRT patients was 94.9% and 92.3%, respectively, compared to 93% and 76.2% for the same ethnic groups in the reference CEV GM. Vaccine uptake was 96.1% for RRT patients in the lowest quartile of the multiple deprivation index, compared to 90.5% in the GM reference population.

CONCLUSION

Bespoke COVID-19 vaccination programmes based on local clinical teams as trusted messengers can improve negative attitudes towards vaccination and reduce health inequalities.

摘要

背景

2019冠状病毒病(COVID-19)疫苗接种改变了COVID-19大流行的局面;然而,已观察到由于疫苗犹豫导致接种率下降,尤其是在少数族裔背景和社会贫困地区的患者中。这些患者特征在接受肾脏替代治疗(RRT)的患者中很常见,这是一群因COVID-19而患重病风险极高的人群,因此将从疫苗接种计划中获益最大。我们为我们的RRT人群设计了一个定制的COVID-19疫苗接种计划,目的是减少健康不平等现象并提高疫苗接种率。

方法

关键干预措施包括通过将各自的临床团队作为可信信使来解决疫苗犹豫问题、及时识别和通知符合条件的患者、调配资源以优化疫苗接种流程使其对患者方便,以及及时收集和分析当地的安全性和有效性数据。首先,分析了我们RRT人群中与种族和社会剥夺相关的COVID-19疫苗接种数据(通过多重剥夺指数衡量),并与大曼彻斯特(GM)地区成年临床极度脆弱(CEV)人群的接种数据进行比较。使用单因素逻辑回归分析来探索与未接种疫苗相关的因素。

结果

在纳入本次分析的1156名RRT患者中,96.7%接种了第一剂疫苗,而GM地区CEV患者队列中的这一比例为93%。年龄、性别、种族和较低的多重剥夺指数未被确定为我们队列中首剂疫苗接种率低的显著风险因素。亚洲和黑人RRT患者的疫苗接种率分别为94.9%和92.3%,而参考CEV GM中相同种族群体的接种率分别为93%和76.2%。多重剥夺指数处于最低四分位数的RRT患者的疫苗接种率为96.1%,而GM参考人群的这一比例为90.5%。

结论

以当地临床团队作为可信信使的定制COVID-19疫苗接种计划可以改善对疫苗接种的消极态度并减少健康不平等现象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a0d/9231261/b55ed7762e42/vaccines-10-00939-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验